menu
    • menu

    Company profile for Carmot Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Carmot Therapeutics is pioneering the discovery and development of innovative drugs for the treatment of metabolic diseases, cancer, and inflammation. Carmot’s vision is to become a leader in drug discovery by generating superior drugs for challenging therapeutic targets. Chemotype Evolution, Carmot’s proprietary technology, enables the rapid identification of novel drugs through an evolutionary discovery paradigm and h...
    Carmot Therapeutics is pioneering the discovery and development of innovative drugs for the treatment of metabolic diseases, cancer, and inflammation. Carmot’s vision is to become a leader in drug discovery by generating superior drugs for challenging therapeutic targets. Chemotype Evolution, Carmot’s proprietary technology, enables the rapid identification of novel drugs through an evolutionary discovery paradigm and has produced a pipeline of breakthrough therapeutics currently in pre-clinical development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Carmot TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    740 Heinz Ave. Berkeley, CA 94710 (888) 402-4674
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://carmot-therapeutics.us/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Next Steps for Roche's High-Cost Obesity Pipeline
    Next Steps for Roche's High-Cost Obesity Pipeline

    19 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/two-years-after-carmot-buyout-whats-next-roches-expensive-obesity-pipeline

    FIERCE BIOTECH
    19 Sep 2025
    Share Share
    Roche Axes Carmot Obesity Asset, 3 Cancer Drugs in R&d Clear-Out
    Roche Axes Carmot Obesity Asset, 3 Cancer Drugs in R&d Clear-Out

    24 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/roche-axes-carmot-obesity-asset-3-cancer-drugs-rd-clearout

    FIERCE BIOTECH
    24 Jul 2025
    Share Share
    LB Pharma Names Heather Turner CEO For Schizophrenia Advances
    LB Pharma Names Heather Turner CEO For Schizophrenia Advances

    19 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/19/2983602/0/en/LB-Pharmaceuticals-Names-Heather-Turner-as-CEO-to-Lead-its-Development-of-Transformative-Advances-in-Schizophrenia-Treatment.html

    GLOBENEWSWIRE
    19 Nov 2024
    Share Share
    Roche targets more than $3 billion in annual obesity sales
    Roche targets more than $3 billion in annual obesity sales

    01 Oct 2024

    // Ludwig Burger REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/roche-targets-more-than-3-billion-annual-obesity-sales-2024-09-30/

    Ludwig Burger REUTERS
    01 Oct 2024
    Share Share
    Roche to fast-track weight loss drugs to compete with rivals, FT reports
    Roche to fast-track weight loss drugs to compete with rivals, FT reports

    29 Jul 2024

    // MONEYCONTROL

    https://www.moneycontrol.com/news/world/roche-to-fast-track-weight-loss-drugs-to-compete-with-rivals-12780802.html

    MONEYCONTROL
    29 Jul 2024
    Share Share
    Roche Completes $2.7B Acquisition of Carmot Therapeutics
    Roche Completes $2.7B Acquisition of Carmot Therapeutics

    29 Jul 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-07-29/roche-completes-27b-acquisition-of-carmot-therapeutics/9769

    CONTRACT PHARMA
    29 Jul 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search